193 related articles for article (PubMed ID: 2060549)
1. Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.
Jansen I; Tfelt-Hansen P; Edvinsson L
Eur J Clin Pharmacol; 1991; 40(1):7-15. PubMed ID: 2060549
[TBL] [Abstract][Full Text] [Related]
2. Effects of extracellular calcium and of the calcium entry blockers flunarizine and nimodipine on contractile responses in human temporal arteries.
Jansen I; Edvinsson L
Cephalalgia; 1986 Dec; 6(4):235-40. PubMed ID: 3802190
[TBL] [Abstract][Full Text] [Related]
3. Involvement of specific receptors and calcium mechanisms in serotonergic contractile response of isolated cerebral and peripheral arteries from rats.
Chang JY; Owman C
J Pharmacol Exp Ther; 1987 Aug; 242(2):629-36. PubMed ID: 3612555
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ca2+ entry blockers on CaCl2-, KCl- and noradrenaline-induced contractions of goat cerebral arteries.
Salom JB; Torregrosa G; Miranda FJ; Alabadí JA; Alvarez C; Alborch E
Eur J Pharmacol; 1990 Feb; 177(1-2):1-8. PubMed ID: 2111247
[TBL] [Abstract][Full Text] [Related]
5. Changes in contractile response and effect of a calcium antagonist, nimodipine, in isolated intracranial arteries of baboon following experimental subarachnoid hemorrhage.
Sahlin C; Owman C; Chang JY; Delgado T; Salford LG; Svendgaard NA
Brain Res Bull; 1990 Mar; 24(3):355-61. PubMed ID: 2337815
[TBL] [Abstract][Full Text] [Related]
6. Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries.
Brandt L; Andersson KE; Edvinsson L; Ljunggren B
J Cereb Blood Flow Metab; 1981; 1(3):339-47. PubMed ID: 6948814
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
Müller-Schweinitzer E; Neumann P
J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility.
Ruiz-Nuño A; Villarroya M; Cano-Abad M; Rosado A; Balfagón G; López MG; García AG
Eur J Pharmacol; 2001 Jan; 411(3):289-99. PubMed ID: 11164387
[TBL] [Abstract][Full Text] [Related]
9. [Nervous disease & Ca antagonist].
Otomo E
No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488
[No Abstract] [Full Text] [Related]
10. Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries.
Alborch E; Salom JB; Perales AJ; Torregrosa G; Miranda FJ; Alabadí JA; Jover T
Eur J Pharmacol; 1992 Dec; 229(1):83-9. PubMed ID: 1473564
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator actions of flunarizine in isolated dog cerebral and extracerebral arteries.
Bian K; Toda N
Jpn J Pharmacol; 1989 Jan; 49(1):83-94. PubMed ID: 2724685
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcium antagonists on endothelin-induced contraction of isolated human resistance arteries: differences related to site of origin.
Sunman W; Martin G; Hair WM; Sever PS; Hughes AD
J Hum Hypertens; 1993 Apr; 7(2):189-91. PubMed ID: 8389874
[TBL] [Abstract][Full Text] [Related]
13. [Nimodipine, nifedipine and the cerebrovascular effects of serotonin].
Semkina GA; Matsievskiĭ DD; Mirzoian RS
Eksp Klin Farmakol; 1996; 59(6):13-6. PubMed ID: 9181863
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries.
Edvinsson L
Acta Physiol Scand; 1985 Sep; 125(1):33-41. PubMed ID: 2864784
[TBL] [Abstract][Full Text] [Related]
15. Effects of nimodipine on in vitro contractility of cerebral arteries of dog, monkey, and man.
Nosko M; Krueger CA; Weir BK; Cook DA
J Neurosurg; 1986 Sep; 65(3):376-81. PubMed ID: 3734887
[TBL] [Abstract][Full Text] [Related]
16. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
17. Flunarizine, an anti-migraine agent, impairs nitroxidergic nerve function in cerebral arteries.
Ayajiki K; Okamura T; Toda N
Eur J Pharmacol; 1997 Jun; 329(1):49-53. PubMed ID: 9218683
[TBL] [Abstract][Full Text] [Related]
18. Ca2+ entry blockers inhibit prostaglandin F2 alpha-induced cerebrovascular contractile responses in goats.
Salom JB; Torregrosa G; Miranda FJ; Alabadí JA; Alvarez C; Alborch E
Eur J Pharmacol; 1991 Oct; 203(1):33-9. PubMed ID: 1797555
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute stroke with calcium antagonists.
Hülser PJ; Kornhuber AW; Kornhuber HH
Eur Neurol; 1990; 30 Suppl 2():35-8; discussion 39-41. PubMed ID: 2180717
[TBL] [Abstract][Full Text] [Related]
20. Calcium-channel blockers in the treatment of migraine.
Gelmers HJ
Am J Cardiol; 1985 Jan; 55(3):139B-143B. PubMed ID: 3881906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
